Back
Gain Therapeutics, Inc. 10K Form
Sell
44
GANX
Gain Therapeutics, Inc.
Last Price:
$3.21
Seasonality Move:
19.87%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive GANX News And Ratings
See the #1 stock for the next 7 days that we like better than GANX
GANX Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-4.9M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.16 |
| Price / Book: | 18.89 |
Profitability
| EPS (TTM): | -0.63930 |
|---|---|
| Net Income (TTM): | $-19.4M |
| Gross Margin: | $-84.1K |
| Return on Equity: | -306.5% |
| Return on Assets: | -164.56% |
Gain Therapeutics, Inc. Earnings Forecast
Key Gain Therapeutics, Inc. Financial Ratios
-
Per Share Earnings over the last 7 years have been positive in 1 years.
Gain Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | GANX |
| Website: | gaintherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0.1 |
|---|---|
| Current Ratio: | 2.52 |
| Quick Ratio: | 2.11 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
GANX Technical Analysis vs Fundamental Analysis
Sell
44
Gain Therapeutics, Inc. (GANX)
is a Sell
Is Gain Therapeutics, Inc. a Buy or a Sell?
-
Gain Therapeutics, Inc. stock is rated a SellThe current Gain Therapeutics, Inc. [GANX] share price is $3.19. The Score for GANX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.